- 积分
- 475
- 威望
- 475
- 包包
- 3248
|
Gene-modified cells could protect against chemotherapy's toxic effects
1 F/ V. a; h% J ^( N5 Z" e" P& R5 {5 r" {
8 I9 N) T" }% u6 N2 NThe usual doses of chemotherapy drugs can cause serious toxic effects in quickly dividing tissues such as the bone marrow.0 Y2 m/ \9 V* E7 ^3 q2 I+ a
! R- D6 E0 M$ D$ W- B8 L7 ^4 H& s
But now, researchers at Fred Hutchinson Cancer Research Centre suggest that one possible approach to reduce this toxic effect on bone marrow cells is to modify the cells with a gene that makes them resistant to chemotherapy.
5 B! M8 R7 i3 R/ ]; G* o6 ^* W B/ G* E) y5 a
Hans-Peter Kiem and colleagues presented data from a clinical trial in which bone marrow stem cells from patients with brain tumors were removed and modified with a retrovirus vector to introduce the chemotherapy-resistant gene. The cells were then re-infused into the patients.
k5 [6 M$ i- E0 E0 C% z$ Q
- m% L3 s* P3 d. ]- D6 MIn the trial, which was designed to evaluate safety and feasibility, patients were safely administered gene-modified blood stem cells that persisted for more than one year and did not show any apparent harmful effects.3 l: W# {6 n$ i% z. y2 L) m" ]4 u
9 l- t0 w! Q* Q"Our initial results are encouraging because our first patient is still alive and without evidence of disease progression almost two years after diagnosis," Kiem said.
9 `$ e) A( a0 z0 g& p6 E
) c9 {: ?$ a( t/ f( l6 O2 gThe results of the trial suggest the administration of the modified cells represent a safe method for protecting marrow and blood cells from the harmful effects of chemotherapy in brain tumor patients. $ h( L) E3 q" |" i0 a( v
/ @. f) L. Y- k& dThe research was reported at the annual meeting of the American Society of Gene and Cell Therapy in Seattle.
+ l& R8 Y7 _3 p2 c) M, s8 [4 o |
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|